The Hartington companies are a group of Pharmaceutical companies with an international presence, the first of which was founded in 1996, and have shown an extraordinary expansion in recent years.
They are dedicated to Biotechnological research, to the development and production of pharmaceutical preparations based on natural substances.
The products are elaborated using the most advanced technology and boast the distinctive seal of excellence.
Is responsible for, fundamentally, the design and implementation of the clinical trials from stages II-IV, and for the production and supply of treatments in the Spanish territory.
In addition, the Spanish office manages Logistics, Business, Marketing, Communication & Public Relations, International Medical Management and Quality Control.
Boasts the principal Quality Control and Development Laboratory, with industrial production capacity. It is responsible for the development of new products, carrying out the preclinical trials, as well as pharmacological, pharmacokinetic and toxicological studies. The centre also carries out clinical safety studies, stability tests, stage I of the clinical trials and is responsible for analytical methods together with drafting the product dossiers.
Is the principal reference for the competent authorities and the European Commission. Essentially, it is responsible for financial matters, dealing with the regulatory bodies, supervising production, the technical preparation of the treatment dossiers, risk analysis, pharmacovigilance and the development and approval of all medical information relevant to the medicine (MDI) and related materials.